Recent clinical trends in Toll‐like receptor targeting therapeutics MA Anwar, M Shah, J Kim, S Choi Medicinal research reviews 39 (3), 1053-1090, 2019 | 258 | 2019 |
Omicron: a heavily mutated SARS-CoV-2 variant exhibits stronger binding to ACE2 and potently escapes approved COVID-19 therapeutic antibodies M Shah, HG Woo Frontiers in immunology 12, 830527, 2022 | 207 | 2022 |
Middle East respiratory syndrome coronavirus: transmission, virology and therapeutic targeting to aid in outbreak control P Durai, M Batool, M Shah, S Choi Experimental & molecular medicine 47 (8), e181-e181, 2015 | 144 | 2015 |
Mutations in the SARS-CoV-2 spike RBD are responsible for stronger ACE2 binding and poor anti-SARS-CoV mAbs cross-neutralization M Shah, B Ahmad, S Choi, HG Woo Computational and Structural Biotechnology Journal 18, 3402-3414, 2020 | 73 | 2020 |
Toll-like receptor-induced cytokines as immunotherapeutic targets in cancers and autoimmune diseases MC Patra, M Shah, S Choi Seminars in cancer biology 64, 61-82, 2020 | 71 | 2020 |
Insights into the species-specific TLR4 signaling mechanism in response to Rhodobacter sphaeroides lipid A detection MA Anwar, S Panneerselvam, M Shah, S Choi Scientific Reports 5 (1), 7657, 2015 | 54 | 2015 |
Resistance of polio to its eradication in Pakistan M Shah, MK Khan, S Shakeel, F Mahmood, Z Sher, MB Sarwar, A Sumrin Virology journal 8, 1-6, 2011 | 51 | 2011 |
TLR4/MD2 specific peptides stalled in vivo LPS-induced immune exacerbation S Park, HJ Shin, M Shah, HY Cho, MA Anwar, A Achek, HK Kwon, B Lee, ... Biomaterials 126, 49-60, 2017 | 48 | 2017 |
A situational analysis of HIV and AIDS in Pakistan M Ilyas, S Asad, L Ali, M Shah, S Badar, MT Sarwar, A Sumrin Virology journal 8, 1-3, 2011 | 46 | 2011 |
In silico mechanistic analysis of IRF3 inactivation and high-risk HPV E6 species-dependent drug response M Shah, MA Anwar, S Park, SS Jafri, S Choi Scientific reports 5 (1), 13446, 2015 | 42 | 2015 |
Molecular docking study of P4-Benzoxaborolesubstituted ligands as inhibitors of HCV NS3/4A protease A Wadood, M Riaz, SB Jamal, M Shah, MA Lodhi Bioinformation 9 (6), 309, 2013 | 39 | 2013 |
In-silico design of peptide inhibitors of K-Ras target in cancer disease M Ghufran, AU Rehman, M Shah, M Ayaz, HL Ng, A Wadood Journal of Biomolecular Structure and Dynamics 38 (18), 5488-5499, 2020 | 38 | 2020 |
A structural insight into the negative effects of opioids in analgesia by modulating the TLR4 signaling: An in silico approach M Shah, MA Anwar, D Yesudhas, J Krishnan, S Choi Scientific reports 6 (1), 39271, 2016 | 38 | 2016 |
Oceans as a source of immunotherapy B Ahmad, M Shah, S Choi Marine Drugs 17 (5), 282, 2019 | 36 | 2019 |
Linear and rationally designed stapled peptides abrogate TLR4 pathway and relieve inflammatory symptoms in rheumatoid arthritis rat model A Achek, M Shah, JY Seo, HK Kwon, X Gui, HJ Shin, EY Cho, BS Lee, ... Journal of medicinal chemistry 62 (14), 6495-6511, 2019 | 34 | 2019 |
Advances in antiviral therapies targeting toll-like receptors M Shah, MA Anwar, JH Kim, S Choi Expert opinion on investigational drugs 25 (4), 437-453, 2016 | 33 | 2016 |
Structural insight into the Middle East respiratory syndrome coronavirus 4a protein and dsRNA binding mechanism B Maria, S Masaud, P Mahesh, Chandra, Y Dhanusha, C and Sangdun Scientific reports, 2017 | 32 | 2017 |
Screening and design of anti-diabetic compounds sourced from the leaves of neem (Azadirachta indica) A Jalil, UA Ashfaq, S Shahzadi, MR Javed, I Rasul, S Rehman, M Shah, ... Bioinformation 9 (20), 1031, 2013 | 32 | 2013 |
Interaction and inhibition of dengue envelope glycoprotein with mammalian receptor DC-sign, an in-silico approach M Shah, A Wadood, Z Rahman, T Husnain PLoS One 8 (3), e59211, 2013 | 31 | 2013 |
Structural-dynamic insights into the H. pylori cytotoxin-associated gene A (CagA) and its abrogation to interact with the tumor suppressor protein ASPP2 using decoy peptides M Junaid, M Shah, A Khan, CD Li, MT Khan, AC Kaushik, A Ali, ... Journal of Biomolecular Structure and Dynamics, 2018 | 30 | 2018 |